During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

More participants in the higher-dose group than placebo achieved an HbA1c under 7% (55.9% vs 15.2%) or under 6.5% (29.4% vs 6 ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin Newsom's initial timeline.

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...

The U.S. Food and Drug Administration has approved Sanofi-Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

Also, in 2023, Sanofi acquired Provention Bio for $25.00 per share in cash, representing an equity value of approximately $2.9 billion. The transaction adds a type 1 diabetes therapy to Sanofi’s ...